• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Note From the Editor-in-Chief

Note From the Editor-in-Chief

June 10, 2020
Benjamin Oldfield
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Benjamin Oldfield Editor-in-Chief of CATR. Clinical Instructor in Medicine and Pediatrics at Yale School of Medicine; Chief Medical Officer at Fair Haven Community Health Care, CT. Dr. Oldfield has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The expansion of telemedicine—which health systems had been slow to adopt and payers had been reluctant to reimburse for years—has zoomed ahead in recent weeks. Sure, it’s not perfect: The video connections can be finicky, and learning new digital platforms can pose challenges for both patients and providers. But with this transition come enormous opportunities to meet patients where they are and minimize their barriers to care.

Lately, I’ve engaged patients in addiction treatment who were previously too fearful to make their symptoms known, or felt too branded to come to the clinic. Now that the opportunities have arrived, it’s on us to develop and refine effective and safe ways to engage patients in addiction treatment via telemedicine. In our next issue (July/August), we’ll address telemedicine as an approach to care for addiction treatment, and weigh the evidence for its use in various models. Good luck to you in your tele-endeavors, keep innovating, and please do share your ideas.

Regards,

Benjamin Oldfield, MD
AskTheEditor@thecarlatreport.com

 
Addiction Treatment
    Benjamin Oldfield

    SAMHSA Relaxes Regulations on Methadone and Buprenorphine During COVID-19 Emergency

    More from this author
    www.thecarlatreport.com
    Issue Date: June 10, 2020
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Emerging Risks for Old Medications, CATR, May/June 2020
    Gabapentin for Alcohol Use Disorder, Redux
    Does Baclofen Titrated to High Doses Reduce Alcohol Use?
    Amphetamines and Topiramate for Cocaine Use Disorder
    E-Cigarettes vs Nicotine Replacement for Smoking Cessation
    Benzodiazepines: Old Medicines, New Concerns
    Muscle Relaxants: Sedatives Often Under the Radar
    SAMHSA Relaxes Regulations on Methadone and Buprenorphine During COVID-19 Emergency
    Gabapentin Misuse and Diversion
    The “Z-Drugs”: Safety Issues and Misuse Potential
    Note From the Editor-in-Chief
    Featured Book
    • OUDFB1e_Cover_Binding.png

      Treating Opioid Use Disorder—A Fact Book (2024)

      All the tools you need to assess and treat patients struggling with opioid use disorder. 
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.